Related Experiment Videos
Large vestibular aqueduct syndrome treated by hyperbaric oxygen
T Nakashima1, H Ueda, A Furuhashi
1Department of Otorhinolaryngology, Nagoya University School of Medicine, Japan.
International Journal of Pediatric Otorhinolaryngology
|January 11, 2000
Summary
Hyperbaric oxygen (HBO) therapy successfully treated sensorineural hearing loss in a patient with large vestibular aqueduct (LVA) syndrome. This treatment is recommended when conventional therapies fail to restore hearing ability.
Area of Science:
- Otolaryngology
- Neurology
- Hyperbaric Medicine
Background:
- Large vestibular aqueduct (LVA) syndrome is a congenital condition often associated with sensorineural hearing loss.
- Sensorineural hearing loss can be profound and progressive, significantly impacting quality of life.
Observation:
- A 14-year-old female presented with abrupt, profound bilateral sensorineural hearing loss.
- Conventional treatments including steroids and prostaglandins were ineffective in restoring her hearing.
Findings:
- Hyperbaric oxygen (HBO) therapy was administered over 22 sessions.
- The patient experienced significant hearing recovery in her affected ear, returning to near pre-abrupt loss levels.
Implications:
- HBO therapy shows promise as an effective treatment for sensorineural hearing loss in LVA syndrome.
- This approach may offer a viable alternative when standard treatments are unsuccessful.